Earnings Call for Q3FY22 of Neogen Chemicals
Conference Call with Neogen Chemicals Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.31-01-2022
31-01-2022
Q3FY22 Quarterly Result Announced for Neogen Chemicals Ltd.
Specialty Chemicals Company Neogen Chemicals declares Q3FY22 result: Revenues in Q3 FY22 increased by 56% to Rs 132.6 crore, as compared to Rs. 85.2 crore in the corresponding quarter last year. The strong performance was driven by higher contribution from the recently commissioned phase I & II expansions at Neogen’s Dahej site. Both demand and realisation stood favourable, led by higher product off-take across key end user industries Profit after tax (PAT) stood at Rs 10.5 crore during the quarter as compared to Rs 8.5 crore in Q3 FY21. PAT growth was muted due to higher finance costs and depreciation, in-line with new capacities added during the year. This will improve once the new plants operate at optimal utilisation levels. Earnings per share for the quarter stood at Rs 4.49 per share (Rs. 3.66 per share in Q3 FY21). Commenting on the Q3 & 9M FY22 performance, Mr. Haridas Kanani, Chairman & Managing Director, Neogen Chemicals said: “I am delighted to share that we have demonstrated robust all-round performance during the quarter under review steered by incremental gains from recently commissioned Phase I & II greenfield expansions at SEZ Dahej, Gujarat. Our revenue growth stood at 56%, translating into highest-ever quarterly revenue run rate of Rs. 133 crore. I am particularly happy that we reported a strong performance despite a challenging macro environment mirrored by sudden spike in utility costs, combined with onset of Omicron variant. I am also happy to share another key development. We successfully raised Rs 225 crore equity on preferential allotment basis to support our growth initiatives in advanced intermediates, custom synthesis and contract manufacturing, and lithium-ion battery materials space. The idea is to be future ready and gain first mover advantage in some of these high potential opportunities, while retaining our balance sheet strength. Post commercialisation of Phase Iⅈ projects, we are now running our Mahape and Vadodara plants at high utilisation levels, while Dahej SEZ plant isramping up. As envisaged, we are now focusing on niche and value-added productsthat require expertise in complex chemistries with multi-stage processes. Our pilot plant initiative of electrolyte manufacturing for lithium-Ion batteries is progressing well and we remain on track to commission that by H1 of FY23. All these initiatives will significantly improve our revenue trajectory over the next few years. The road ahead appears equally exciting for us, and we remain vigilant of growing opportunities in the chemicals and lithium-ion battery materials for EV (electric vehicles) space. We will continue to use our expertise and capabilities to deliver sustainable and profitable performance.” Result PDF30-01-2022
Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation
With reference to the captioned subject, please find enclosed herewith the Earnings Presentation on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2021.30-01-2022
Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, please find enclosed herewith the Press Release on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2021.30-01-2022
Neogen Chemicals Ltd - 542665 - Financial Results Q3FY22
With regards to the captioned subject and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday, January 29, 2022 which commenced at 3.00 p.m. (IST) and concluded at 5.05 p.m. (IST), inter alia, considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2021, pursuant to Regulation 33 of the Listing Regulations along with the 'Limited Review Report' thereon as submitted by the Statutory Auditors of the Company and duly reviewed and recommended by the Audit Committee and the same is enclosed herewith;29-01-2022
Neogen Chemicals Ltd - 542665 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, January 29, 2022.
With regards to the captioned subject and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday, January 29, 2022 which commenced at 3.00 p.m. (IST) and concluded at 5.05 p.m. (IST), inter alia, considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2021, pursuant to Regulation 33 of the Listing Regulations along with the 'Limited Review Report' thereon as submitted by the Statutory Auditors of the Company and duly reviewed and recommended by the Audit Committee and the same is enclosed herewith;29-01-2022
Specialty chemicals maker Neogen's shares double in 1 year on PLI boost
Shares of Neogen Chemicals have more than doubled in the past one-year period after the Centre announced production-linked incentives (PLIs) for specialty chemical manufacturers.26-01-2022
Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 (6) of the Listing Regulations, we would like to inform you that the Company will participate in the earnings conference call on Monday, January 31, 2022 at 4.30 p.m. IST for analysts and investors to discuss the Q3 & 9M FY22 results.24-01-2022
Neogen Chemicals Ltd - 542665 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 (' Listing Regulations')
Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2022 ,inter alia, to consider and approve Pursuant to regulation 29 of the Listing Regulations, notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, January 29, 2022, inter alia, to consider, approve and take on record the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2021, along with limited review report of the Statutory Auditors thereon.22-01-2022
Neogen Chemicals Ltd - 542665 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Axis Childrens Gift Fund, Axis Flexi Cap Fund, Axis Small Cap Fund, Axis Special Situations Fund, Axis Regular Saver Fund (Schemes of Axis Mutual Fund)21-01-2022